Biodecode International Medical Research Co., Ltd. is a healthcare innovation-driven organization dedicated to integrating cutting-edge life science technologies with clinical medical applications, aiming to provide global users with precise and personalized health management solutions. The company’s flagship initiative, the "Dr. Bob Miller Project," is built upon three decades of pioneering research and academic achievements by Dr. Bob Miller, a leading functional genomics expert in North America. This project establishes an integrated service system encompassing medical education, genetic testing, intelligent analysis, and health interventions. The company’s core operations span four key sectors: ​​Medical Training and Certification​​: Delivering systematic, internationally accredited curricula to empower healthcare professionals with authoritative qualifications. ​​Comprehensive Functional Genome Testing​​: Leveraging high-throughput sequencing technology to decode individual genomic profiles thoroughly. ​​AI-Driven Genetic Analysis​​: Utilizing deep learning algorithms to generate precise health risk assessment reports, enhancing interpretative efficiency and scientific rigor. ​​Personalized Nutrient Intervention​​: Developing custom precision nutrition plans based on genetic data and clinical indicators to optimize disease prevention and health outcomes. Anchored by its "Genetics + AI + Medicine" technological framework, Lingtu International unites cross-disciplinary experts to advance the accessibility of precision medicine globally, empowering individuals to elevate their quality of life. Upholding the philosophy of "Science as Our Foundation, Health as Our Priority," the company continues to push the boundaries of life science innovation, forging new paradigms in the future of healthcare.